CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Comparison of the Efficacy of Glimepiride, Metformin, and Rosiglitazone Monotherapy in Korean Drug-Naïve Type 2 Diabetic Patients: The Practical Evidence of Antidiabetic Monotherapy Study
Kun Ho Yoon, Jeong Ah Shin, Hyuk Sang Kwon, Seung Hwan Lee, Kyung Wan Min, Yu Bae Ahn, Soon Jib Yoo, Kyu Jeung Ahn, Sung Woo Park, Kwan Woo Lee, Yeon Ah Sung, Tae Sun Park, Min Seon Kim, Yong Ki Kim, Moon Suk Nam, Hye Soon Kim, Ie Byung Park, Jong Suk Park, Jeong Taek Woo, Ho Young Son
Diabetes Metab J. 2011;35(1):26-33.   Published online February 28, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.1.26

Excel Download

What Is the Optimal Monotherapy in Korean Drug-Naïve Type 2 Diabetic Patients?: The Practical Evidence of Antidiabetic Monotherapy Study
Diabetes & Metabolism Journal. 2011;35(1):23   Crossref logo
Link1 Link2 Link3

Comparison of the Efficacy of Glimepiride, Metformin, and Rosiglitazone Monotherapy in Korean Drug-Naïve Type 2 Diabetic Patients: The Practical Evidence of Antidiabetic Monotherapy Study
Diabetes & Metabolism Journal. 2011;35(1):26   Crossref logo
Link1 Link2 Link3

Improved glycaemic control by addition of glimepiride to metformin monotherapy in Type 2 diabetic patients
Diabetic Medicine. 2001;18(10):828-834   Crossref logo
Link1 Link2 Link3

The effects of triple vs. dual and monotherapy with rosiglitazone, glimepiride, and atorvastatin on lipid profile and glycemic control in type 2 diabetes mellitus rats
Fundamental & Clinical Pharmacology. 2011;26(5):621-631   Crossref logo
Link1 Link2

PDB18 COMPARISON OF RESOURCES UTILIZATION (RU)AND COST IN DRUG NAÏVE TYPE 2 DIABETES (T2D) PATIENTS TREATED WITH ROSIGLITAZONE (RSG)VS. SULFONYLUREA (SU) MONOTHERAPY
Value in Health. 2008;11(3):A223   Crossref logo
Link1 Link2

Rosiglitazone monotherapy and Type 2 diabetes
Diabetic Medicine. 2001;18:6-8   Crossref logo
Link1 Link2 Link3

Efficacy of glimepiride/metformin fixed-dose combination vs metformin uptitration in type 2 diabetic patients inadequately controlled on low-dose metformin monotherapy: A randomized, open label, parallel group, multicenter study in Korea
Journal of Diabetes Investigation. 2014;5(6):701-708   Crossref logo
Link1 Link2 Link3

Efficacy and safety of initial combination therapy with alogliptin plus metformin versus either as monotherapy in drug-naïve patients with type 2 diabetes: a randomized, double-blind, 6-month study
Diabetes, Obesity and Metabolism. 2014;16(7):613-621   Crossref logo
Link1 Link2

Durable efficacy of metformin/glibenclamide* combination tablets (Glucovance®) during 52 weeks of open-label treatment in type 2 diabetic patients with hyperglycaemia despite previous sulphonylurea monotherapy
International Journal of Clinical Practice. 2004;58(9):820-826   Crossref logo
Link1 Link2

Response to Pokharna and Kanna: Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes
Diabetes, Obesity and Metabolism. 2008;10(5):436-437   Crossref logo
Link1 Link2